Lei Changjuan - Net Worth and Insider Trading

Lei Changjuan Net Worth

The estimated net worth of Lei Changjuan is at least $3 Million dollars as of 2024-09-22. Lei Changjuan is the 2101 Beneficial owner of China Regenerative Medicine International Ltd and owns about 26,240,000 shares of China Regenerative Medicine International Ltd (HKSE:08158) stock worth over $3 Million. Details can be seen in Lei Changjuan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lei Changjuan has not made any transactions after 2020-12-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Lei Changjuan

To

Lei Changjuan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Lei Changjuan owns 1 companies in total, including China Regenerative Medicine International Ltd (HKSE:08158) .

Click here to see the complete history of Lei Changjuan’s form 4 insider trades.

Insider Ownership Summary of Lei Changjuan

Ticker Comapny Transaction Date Type of Owner
HKSE:08158 China Regenerative Medicine International Ltd 2020-12-18 2101 Beneficial owner

Lei Changjuan Latest Holdings Summary

Lei Changjuan currently owns a total of 1 stock. Lei Changjuan owns 26,240,000 shares of China Regenerative Medicine International Ltd (HKSE:08158) as of December 18, 2020, with a value of $3 Million.

Latest Holdings of Lei Changjuan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:08158 China Regenerative Medicine International Ltd 2020-12-18 26,240,000 0.10 2,571,520

Holding Weightings of Lei Changjuan


Lei Changjuan Form 4 Trading Tracker

According to the SEC Form 4 filings, Lei Changjuan has made a total of 1 transactions in China Regenerative Medicine International Ltd (HKSE:08158) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in China Regenerative Medicine International Ltd is the acquisition of 10,890,000 shares on December 18, 2020, which cost Lei Changjuan around $0.

Insider Trading History of Lei Changjuan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Lei Changjuan Trading Performance

GuruFocus tracks the stock performance after each of Lei Changjuan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lei Changjuan is -23.29%. GuruFocus also compares Lei Changjuan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Lei Changjuan within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Lei Changjuan's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Lei Changjuan

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -47.26 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -48.85 LIMIT LIMIT LIMIT LIMIT LIMIT

Lei Changjuan Ownership Network

Ownership Network List of Lei Changjuan

No Data

Ownership Network Relation of Lei Changjuan

Insider Network Chart

Lei Changjuan Owned Company Details

What does China Regenerative Medicine International Ltd do?

Who are the key executives at China Regenerative Medicine International Ltd?

Lei Changjuan is the 2101 Beneficial owner of China Regenerative Medicine International Ltd. Other key executives at China Regenerative Medicine International Ltd include 2101 Beneficial owner Wang Chuang , 2501 Other Arab Osman Mohammed , and 2501 Other Wong Kwok Keung .

China Regenerative Medicine International Ltd (HKSE:08158) Insider Trades Summary

Over the past 18 months, Lei Changjuan made no insider transaction in China Regenerative Medicine International Ltd (HKSE:08158). Other recent insider transactions involving China Regenerative Medicine International Ltd (HKSE:08158) include a net sale of 0 shares made by Wang Chuang ,

In summary, during the past 3 months, insiders sold 0 shares of China Regenerative Medicine International Ltd (HKSE:08158) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of China Regenerative Medicine International Ltd (HKSE:08158) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

China Regenerative Medicine International Ltd (HKSE:08158)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

China Regenerative Medicine International Ltd Insider Transactions

No Available Data

Lei Changjuan Mailing Address

Above is the net worth, insider trading, and ownership report for Lei Changjuan. Currently GuruFocus does not have mailing address information for Lei Changjuan.

Discussions on Lei Changjuan

No discussions yet.